Each of the anti-SARS-CoV-2 mAbs was able to neutralize pseudo-typed lentiviruses coated with SARS-CoV-2 S protein during the infection of ACE2-expressing CRFK cells (Figure 8a,b). This evidence concerns the gene ACE2 and infection.